Bristol-Myers Squibb (BMY) News Today → Nvidia CEO Says It Will Be “the Next Revolution” Beyond AI (From Banyan Hill Publishing) (Ad) Free BMY Stock Alerts $44.65 -0.20 (-0.45%) (As of 04/29/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineVan ECK Associates Corp Has $206.83 Million Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)marketbeat.com - April 29 at 9:08 PMJudge rejects J&J, Bristol Myers Squibb challenges to Medicare drug price negotiationscnbc.com - April 29 at 6:22 PMJ&J, Bristol Myers lose challenges to US drug price negotiation programreuters.com - April 29 at 5:57 PMBristol-Myers Squibb (NYSE:BMY) Stock Price Up 0.1%marketbeat.com - April 29 at 3:52 PMAfter 'reset,' Flagship startup lands $1.8B Bristol Myers Squibb dealbizjournals.com - April 29 at 8:28 AMBristol Myers, Repertoire to develop tolerizing vaccines in multi-year pactmsn.com - April 29 at 8:28 AMBristol-Myers Squibb Q1 Earnings Transcriptmarketbeat.com - April 29 at 7:06 AMRepertoire® Immune Medicines and Bristol Myers Squibb Announce Multi-Year Strategic Collaboration to Develop Tolerizing Vaccines for Autoimmune Diseasesprnewswire.com - April 29 at 6:00 AMBristol-Myers Squibb Expected to Earn Q2 2024 Earnings of $1.76 Per Share (NYSE:BMY)americanbankingnews.com - April 29 at 1:58 AMRaymond James & Associates Acquires 922,165 Shares of Bristol-Myers Squibb (NYSE:BMY)marketbeat.com - April 28 at 11:10 PMBristol-Myers Squibb (NYSE:BMY) PT Lowered to $43.00americanbankingnews.com - April 28 at 5:46 AMBristol-Myers Squibb (NYSE:BMY) PT Lowered to $48.00americanbankingnews.com - April 28 at 5:02 AMPFG Investments LLC Acquires 56,932 Shares of Bristol-Myers Squibb (NYSE:BMY)marketbeat.com - April 27 at 10:17 PMBristol-Myers Squibb First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lagsfinance.yahoo.com - April 27 at 12:11 PMBristol-Myers Squibb to Cut 2,200 Jobs as Part of $1.5 Billion Cost-Cutting Effortwsj.com - April 27 at 7:10 AMBristol-Myers Squibb (NYSE:BMY) Reaches New 1-Year Low at $45.11americanbankingnews.com - April 27 at 6:04 AMBristol-Myers Squibb: Hold Rating Amid Mixed Performance and Future Revenue Concernsmarkets.businessinsider.com - April 27 at 5:01 AMBristol-Myers Squibb (NYSE:BMY) Shares Up 1.4% Following Strong Earningsamericanbankingnews.com - April 27 at 3:16 AMIs Bristol Myers Squibb Stock a Millionaire Maker?msn.com - April 26 at 9:09 PMMeritage Portfolio Management Has $785,000 Stake in Bristol-Myers Squibb (NYSE:BMY)marketbeat.com - April 26 at 3:16 PMBristol-Myers Squibb (NYSE:BMY) Price Target Cut to $48.00marketbeat.com - April 26 at 2:43 PMBristol Myers: CHMP Recommends Approval Of Opdivo In Combination With Cisplatin And Gemcitabinemarkets.businessinsider.com - April 26 at 1:59 PMPeeling Back The Layers: Exploring Bristol-Myers Squibb Through Analyst Insightsmarkets.businessinsider.com - April 26 at 1:59 PMBristol-Myers Squibb (NYSE:BMY) Trading 1.4% Higher After Strong Earningsmarketbeat.com - April 26 at 12:34 PMCHMP Adopts Positive Opinion Recommending Approval of Bristol Myers Squibb’s Opdivo® (nivolumab) in Combination with Cisplatin and Gemcitabine for the First-Line Treatment of Adult Patients with Unresectable or Metastatic Urothelial Carcinomafinance.yahoo.com - April 26 at 8:57 AMCHMP Adopts Positive Opinion Recommending Approval of Bristol Myers Squibb's Opdivo® (nivolumab) in Combination with Cisplatin and Gemcitabine for the First-Line Treatment of Adult Patients with Unresectable or Metastatic Urothelial Carcinomabusinesswire.com - April 26 at 6:59 AMBristol-Myers Squibb Co. (BMY) Discloses Financial and Operational Insights Within Their Latest Quarterly Reportamericanbankingnews.com - April 26 at 4:06 AMQ2 2024 Earnings Forecast for Bristol-Myers Squibb Issued By Zacks Research (NYSE:BMY)americanbankingnews.com - April 26 at 2:20 AMBristol-Myers Q1 Loss Narrower Than Expected, Sales Beatmarkets.businessinsider.com - April 26 at 1:44 AMQ1 2024 Bristol-Myers Squibb Co Earnings Callfinance.yahoo.com - April 25 at 10:57 PMBristol-Myers to cut 2,200 jobs as part of $1.5B cost saving planmsn.com - April 25 at 8:43 PMBristol-Myers Squibb (NYSE:BMY) Shares Bought by Bank Julius Baer & Co. Ltd Zurichmarketbeat.com - April 25 at 8:34 PMBristol-Myers Squibb (NYSE:BMY) Trading Down 7.5%marketbeat.com - April 25 at 7:45 PMAstraZeneca Flirts With A Breakout After Cancer Drug Sales Shine; Sanofi, Bristol Stocks Divergefinance.yahoo.com - April 25 at 5:56 PMBristol Myers Squibb stock tumbles on cost-cutting initiativefinance.yahoo.com - April 25 at 5:56 PMBristol-Myers Squibb Stock: Gloomy Q1 Earnings Trigger Justified Sell-Offseekingalpha.com - April 25 at 3:56 PMCrude Oil Moves Higher; Bristol Myers Squibb Shares Fall After Q1 Resultsbenzinga.com - April 25 at 3:42 PMBristol-Myers posts Q1 beat despite growth headwindsmsn.com - April 25 at 3:42 PMBristol Myers Squibb (BMY) Q1 2024 Earnings Call Transcriptmsn.com - April 25 at 3:42 PMBiotech Stock Roundup: BIIB, BMY's Q1 Earnings, INCY's Acquisition & Updates from VRTXfinance.yahoo.com - April 25 at 3:42 PMBMY Stock Earnings: Bristol-Myers Squibb Beats EPS, Beats Revenue for Q1 2024investorplace.com - April 25 at 1:08 PMUpdate: Bristol-Myers Squibb Swings to Q1 Non-GAAP Loss, Revenue Rises; Provides 2024 Guidance -- Shares Fallfinance.yahoo.com - April 25 at 12:55 PMBristol-Myers Squibb Layoffs 2024: What to Know About the Latest BMY Job Cutsinvestorplace.com - April 25 at 12:10 PMWhy Bristol Myers Squibb Stock Is Sinking Todayfool.com - April 25 at 11:57 AMBristol-Myers Squibb Layoffs 2024: What to Know About the Latest BMY Job Cutsinvestorplace.com - April 25 at 11:50 AMBristol-Myers Squibb (NYSE:BMY) Releases Quarterly Earnings Results, Beats Estimates By $0.10 EPSmarketbeat.com - April 25 at 10:45 AMMerck jumps on profit beat as Bristol Myers Squibb slips to a lossproactiveinvestors.com - April 25 at 9:51 AMBristol-Myers Squibb (NYSE:BMY) Releases FY24 Earnings Guidancemarketbeat.com - April 25 at 8:43 AMBristol Myers Cuts Full-Year Earnings Forecast, Launches Cost Cutsbarrons.com - April 25 at 8:36 AMBristol-Myers Squibb Co (BMY) Q1 2024 Earnings Report: A Detailed Overviewgurufocus.com - April 25 at 8:24 AM Get Bristol-Myers Squibb News Delivered to You Automatically Sign up to receive the latest news and ratings for BMY and its competitors with MarketBeat's FREE daily newsletter. Email Address Nvidia CEO Says It Will Be “the Next Revolution” Beyond AI (Ad)Nvidia’s CEO calls it the “next amazing revolution” … and even declared it “is going to be flat out of the biggest [revolution] ever.” Jeff Bezos, Bill Gates, and Mark Zuckerberg have invested billions in it. Click on Adam's shiny forehead for more details. BMY Media Mentions By Week BMY Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BMY News Sentiment▼0.130.34▲Average Medical News Sentiment BMY News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BMY Articles This Week▼8022▲BMY Articles Average Week Get Bristol-Myers Squibb News Delivered to You Automatically Sign up to receive the latest news and ratings for BMY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Zoetis News Today Pfizer News Today AbbVie News Today Merck & Co., Inc. News Today Johnson & Johnson News Today Regeneron Pharmaceuticals News Today Vertex Pharmaceuticals News Today GSK News Today Sanofi News Today Takeda Pharmaceutical News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:BMY) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsNvidia CEO Says It Will Be “the Next Revolution” Beyond AIBanyan Hill PublishingCharles Payne’s Gift to Stock InvestorsUnstoppable ProsperityProtect Your Bank Account Before It’s Too LateWeiss RatingsHe Is Giving Away BitcoinCrypto Swap ProfitsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press4 coins to be the “Next Bitcoin”True Market InsidersThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bristol-Myers Squibb Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
